Bionime Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 475.65 million compared to TWD 463.8 million a year ago. Net income was TWD 13.79 million compared to TWD 11.93 million a year ago. Basic earnings per share from continuing operations was TWD 0.23 compared to TWD 0.2 a year ago. Diluted earnings per share from continuing operations was TWD 0.23 compared to TWD 0.2 a year ago.